Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial.
Lancet Infect Dis
; 17(3): 322-329, 2017 03.
Article
in En
| MEDLINE
| ID: mdl-28007428
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lyme Disease
/
Azithromycin
/
Antibiotic Prophylaxis
/
Anti-Bacterial Agents
Type of study:
Clinical_trials
Limits:
Adult
/
Animals
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Lancet Infect Dis
Journal subject:
DOENCAS TRANSMISSIVEIS
Year:
2017
Document type:
Article
Affiliation country:
Austria
Country of publication:
Estados Unidos